JPH0551271B2 - - Google Patents
Info
- Publication number
- JPH0551271B2 JPH0551271B2 JP58213613A JP21361383A JPH0551271B2 JP H0551271 B2 JPH0551271 B2 JP H0551271B2 JP 58213613 A JP58213613 A JP 58213613A JP 21361383 A JP21361383 A JP 21361383A JP H0551271 B2 JPH0551271 B2 JP H0551271B2
- Authority
- JP
- Japan
- Prior art keywords
- fatty acids
- eggs
- omega
- vitamin
- egg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000013601 eggs Nutrition 0.000 claims description 25
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 18
- 239000003651 drinking water Substances 0.000 claims description 12
- 235000020188 drinking water Nutrition 0.000 claims description 12
- 244000144977 poultry Species 0.000 claims description 9
- 235000013402 health food Nutrition 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000013345 egg yolk Nutrition 0.000 description 7
- 210000002969 egg yolk Anatomy 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 6
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 235000020778 linoleic acid Nutrition 0.000 description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 229940013317 fish oils Drugs 0.000 description 3
- -1 glycerin fatty acid esters Chemical class 0.000 description 3
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 241000555825 Clupeidae Species 0.000 description 2
- 241000442132 Lactarius lactarius Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001290266 Sciaenops ocellatus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Landscapes
- Meat, Egg Or Seafood Products (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
本発明は健康食品卵、更に詳細には、ω3系高
度不飽和脂肪酸を含有する健康食品卵の生産方法
に関する。
卵は栄養価が高く、バランスのとれた栄養成分
が含まれた優れた食品であるが、コレステロール
含量が高いので、その摂取量を制限しなければな
らない。そこで、近年卵中に種々の薬剤を含有せ
しめて血中コレステロールの上昇を抑制しようと
いう研究が行われ、多くの報告がなされている。
一方、天然油脂、例えばサバ、イワシ、等の多
獲性赤身魚、タラ等の多獲性白身魚及びイカ類の
魚油中に含まれているω3系高度不飽和脂肪酸が
血中コレステロールを減少させる作用を有するこ
とが報告され（例えば特開昭54−154533号参照）
て以来、これを血栓症等の治療予防剤として使用
せんとする研究が盛んになつてきた。
しかし、新鮮魚体中に含まれる油脂量には自ず
と限度があり、更に、近年、食生活の変化に伴
い、新鮮多獲性魚類の摂取量が減少する傾向にあ
る。従つて、ω3系高度不飽和脂肪酸を一般の食
生活から摂取することは困難な状況にある。
一方、魚油として食用に供することは、魚臭が
著しく嗜好面での実用性に劣る。
斯かる実情において、本発明者は鋭意研究を行
つた結果、ω3系高度不飽和脂肪酸を乳化せしめ
た飲水を採卵用家禽に与えて飼育すれば、ω3系
高度不飽和脂肪酸を多量に含む卵が生産されるこ
とを見出し、本発明を完成した。
すなわち、本発明は採卵用家禽にω3系高度不
飽和脂肪酸を乳化せしめた飲水を与えて飼育して
健康食品卵を生産する方法である。
本発明方法において、飲水に配合されるω3系
高度不飽和脂肪酸は純品であつても、またこれを
含むものであつてもよいが、一般には天然油脂
（サバ、イワシ等の多獲性赤身魚、タラ等の多獲
性白身魚及びイカ類の魚油）、またはこれを常法
に従つてケン化したもの、あるいは更にメチルま
たはエチルエステル化したものが好ましい。魚油
または魚油エステルはそのままでは水に溶解しな
いので適宜乳化剤等にて乳化せしめることが必要
である。ここに乳化剤としては例えばグリセリン
脂肪酸エステル、蔗糖脂肪酸エステル、ソルビタ
ン脂肪酸エステル、レシチン等のｏ／ｗ型乳化剤
が好適である。
ω3系高度不飽和脂肪酸の飲水中への添加量は、
ω3系高度不飽和脂肪酸として0.1〜３％になるよ
うにするのが好ましい。
このような飲水を８日間以上与えるとω3系高
度不飽和脂肪酸を多量、例えば卵黄100ｇ当り0.5
ｇ以上を含む卵が生産される。飲水へのω3系高
度不飽和脂肪酸配合量が0.1％未満では卵黄100ｇ
当り0.5ｇ以上のω3系高度不飽和脂肪酸を含む卵
が得られず、また配合量が３％を越えても卵黄中
のω3系高度不飽和脂肪酸量はこれ以上増加しな
いと共に、嗜好性が悪くなり、家禽の飲水量が減
少するので、発育や産卵率が低下し好ましくな
い。
尚、本発明の実施に当たり、上記のω3系高度
不飽和脂肪酸を乳化せしめた飲水に更にリノール
酸又は（及び）脂溶性ビタミン特にビタミンＥ又
は（及び）ビタミンＡを配合したものを家禽に与
えて飼育すれば、ω3系高度不飽和脂肪酸の他に
リノール酸、ビタミンＥ、ビタミンＡを含む卵を
生産せしめることができる。
ここで使用されるリノール酸はそれ自体でも又
これを含むものでもよく、例えばこの含有量の多
い大豆油、サフラワー油等の植物油が一般に使用
される。リノール酸、ビタミンＥ、ビタミンＡの
配合量は、飲水100ｇ中にそれぞれ１〜10ｇ、
0.02〜１ｇ、５千〜10万単位になるようにするの
が好ましい。
叙上の如くして本発明方法で生産される健康食
品卵は多量のω3系高度不飽和脂肪酸を含んでい
るので、これを摂取すると血中コレステロールを
低下させ、高血圧、血栓症を予防ないし治療する
ことができると共に、卵の摂取による高コレステ
ロール化を防止できる。
次に実施例を挙げて説明する。
実施例 １
水600Kgにω85乳化オイル〔エイコサペンタエ
ン酸（EPA）28.7％含有、ドコサヘキサエン酸
（DHA）51.3％含有：日本化学飼料社製〕を６Kg
添加して飲水を調製し、これを100羽の家禽に自
由給飼させて飼育し、初日及び一週毎３週間に渡
り産卵した卵について卵黄中のω3系高度不飽和
脂肪酸のDHA，EPA量について測定した。
尚、この家禽の飼育にあたつての飼料は産卵鶏
用オールマイテイ（日清製粉社製）を給飼した。
その結果、第１表で示される通り、３週間後の
卵には卵黄100ｇ当りEPA160mg、DHA1280mgを
含む卵が生産された。
The present invention relates to a health food egg, and more particularly to a method for producing a health food egg containing omega-3 highly unsaturated fatty acids. Eggs are a highly nutritious and well-balanced food, but their intake must be limited due to their high cholesterol content. Therefore, in recent years, research has been conducted to suppress the rise in blood cholesterol by incorporating various drugs into eggs, and many reports have been made. On the other hand, natural oils and fats, such as omega-3 polyunsaturated fatty acids contained in fish oils from high-catch red fish such as mackerel and sardines, high-catch white fish such as cod, and squid, reduce blood cholesterol. It has been reported that it has an effect (for example, see JP-A-54-154533).
Since then, there has been active research into using it as a therapeutic and preventive agent for thrombosis, etc. However, there is a natural limit to the amount of oil and fat contained in fresh fish, and furthermore, in recent years, with changes in dietary habits, the amount of fresh fish that can be caught has tended to decrease. Therefore, it is difficult to intake omega-3 polyunsaturated fatty acids from the general diet. On the other hand, when used as fish oil for human consumption, it has a very fishy odor and is not practical in terms of taste. Under these circumstances, the present inventor conducted intensive research and found that if poultry for egg collection are fed drinking water emulsified with omega-3 polyunsaturated fatty acids and raised, eggs containing a large amount of omega-3 polyunsaturated fatty acids will be produced. They discovered that it can be produced and completed the present invention. That is, the present invention is a method for producing eggs as a health food by feeding poultry for egg collection with drinking water emulsified with omega-3 polyunsaturated fatty acids. In the method of the present invention, the omega-3 polyunsaturated fatty acids added to the drinking water may be pure or contain them, but are generally natural fats and oils (highly harvested red meat such as mackerel and sardines). Preferred are fish oils, fish oils from white fish such as fish, cod, etc., and squids), saponified oils according to conventional methods, or methyl or ethyl esterified oils. Since fish oil or fish oil ester does not dissolve in water as it is, it is necessary to emulsify it with an appropriate emulsifier or the like. Suitable emulsifiers here include o/w type emulsifiers such as glycerin fatty acid esters, sucrose fatty acid esters, sorbitan fatty acid esters, and lecithin. The amount of omega-3 highly unsaturated fatty acids added to drinking water is
It is preferable that the amount of omega-3 highly unsaturated fatty acids be 0.1 to 3%. If you give this type of drinking water for more than 8 days, it will contain a large amount of omega-3 polyunsaturated fatty acids, for example 0.5 per 100g of egg yolk.
Eggs containing more than g are produced. If the content of omega-3 polyunsaturated fatty acids in drinking water is less than 0.1%, 100g of egg yolk
It is not possible to obtain eggs containing 0.5g or more of ω3 polyunsaturated fatty acids per egg, and even if the amount exceeds 3%, the amount of ω3 polyunsaturated fatty acids in the egg yolk does not increase any further, and the palatability is poor. As a result, the amount of water the poultry drinks is reduced, which is undesirable as it reduces growth and egg production rate. In carrying out the present invention, poultry are given drinking water in which the above-mentioned omega-3 highly unsaturated fatty acids are emulsified and further mixed with linoleic acid or (and) a fat-soluble vitamin, especially vitamin E or (and) vitamin A. If bred, it is possible to produce eggs containing linoleic acid, vitamin E, and vitamin A in addition to omega-3 polyunsaturated fatty acids. The linoleic acid used here may be itself or one containing linoleic acid; for example, vegetable oils containing a large amount of linoleic acid, such as soybean oil and safflower oil, are generally used. The amount of linoleic acid, vitamin E, and vitamin A is 1 to 10 g each in 100 g of drinking water.
Preferably, the amount is 0.02 to 1 g and 5,000 to 100,000 units. As mentioned above, the health food egg produced by the method of the present invention contains a large amount of omega-3 polyunsaturated fatty acids, so when ingested, it lowers blood cholesterol and prevents or treats high blood pressure and thrombosis. In addition, it is possible to prevent high cholesterol levels due to egg intake. Next, an example will be given and explained. Example 1 6 kg of ω85 emulsified oil [containing 28.7% eicosapentaenoic acid (EPA), 51.3% docosahexaenoic acid (DHA): manufactured by Nippon Chemical Feed Co., Ltd.] was added to 600 kg of water.
The amounts of DHA and EPA of omega-3 polyunsaturated fatty acids in the egg yolks of the eggs laid on the first day and every week for 3 weeks after 100 poultry were reared and fed with ad libitum drinking water. It was measured. The poultry was fed with All Mighty (manufactured by Nisshin Seifun Co., Ltd.) for laying hens. As a result, as shown in Table 1, eggs containing 160 mg of EPA and 1280 mg of DHA per 100 g of egg yolk were produced after 3 weeks.
【表】
実施例 ２
水600Kgにω85乳化オイル（実施例１と同一）
を６Kg、リノール酸（リノール酸48％含有の大豆
油として）1.5Kg、ビタミンE0.12Kg、ビタミン
A6000万単位を添加して飲水を調製し、これを
100羽の家禽に自由給飼させて飼育し、４週間目
に産卵した卵について卵黄中のEPA，DHA、リ
ノール酸、ビタミンＥ、ビタミンＡ量について測
定した。
尚、この家禽の飼育にあたつての飼料は実施例
１と同様産卵鶏用オールマイテイ（日清製粉製社
製）を給飼した。対照区の飲水は単なる水を給飼
した。
その結果、第２表で示される通り４週間後の卵
には卵黄100ｇ当り、リノール酸5.5mg、ビタミン
E5.1mg及びビタミンA4100単位以上を含む卵が生
産された。尚、参考に市販の卵を測定した結果
EPA0mg、DHA16mg、リノール酸3.2mg、ビタミ
ンE2.1mgそしてビタミンA1600単位であつた。[Table] Example 2 ω85 emulsified oil in 600 kg of water (same as Example 1)
6 kg, linoleic acid (as soybean oil containing 48% linoleic acid) 1.5 kg, vitamin E 0.12 kg, vitamin
Prepare drinking water by adding 60 million units of A;
100 poultry were raised with ad libitum feeding, and the amounts of EPA, DHA, linoleic acid, vitamin E, and vitamin A in the egg yolks of eggs laid in the fourth week were measured. The poultry was fed with All Mighty (manufactured by Nisshin Seifun Seifun Co., Ltd.) for egg-laying hens as in Example 1. The control group was provided with plain water for drinking water. As a result, as shown in Table 2, eggs after 4 weeks contained 5.5 mg of linoleic acid and vitamin B per 100 g of egg yolk.
Eggs containing 5.1 mg of E and over 4100 units of vitamin A were produced. For reference, the results of measuring commercially available eggs
It contained 0 mg of EPA, 16 mg of DHA, 3.2 mg of linoleic acid, 2.1 mg of vitamin E, and 1600 units of vitamin A.
Claims (1)
〜３重量％になるようにｏ／ｗ型乳化剤を用いて
乳化せしめた飲水を与えて飼育することを特徴と
する健康食品卵の生産方法。 ２ ω3系高度不飽和脂肪酸が魚油又は魚油エス
テルである特許請求の範囲第１項記載の健康食品
卵の生産方法。[Claims] 1. Adding 0.1 ω3 polyunsaturated fatty acids to poultry for egg collection.
A method for producing eggs as a health food, the method comprising raising the eggs with drinking water emulsified using an o/w emulsifier to a concentration of ~3% by weight. 2. The method for producing eggs as a health food according to claim 1, wherein the ω3 highly unsaturated fatty acid is fish oil or fish oil ester.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58213613A JPS60105471A (en) | 1983-11-14 | 1983-11-14 | Production of health food egg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58213613A JPS60105471A (en) | 1983-11-14 | 1983-11-14 | Production of health food egg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60105471A JPS60105471A (en) | 1985-06-10 |
| JPH0551271B2 true JPH0551271B2 (en) | 1993-08-02 |
Family
ID=16642072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58213613A Granted JPS60105471A (en) | 1983-11-14 | 1983-11-14 | Production of health food egg |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60105471A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038051A1 (en) * | 1995-05-30 | 1996-12-05 | Suntory Limited | Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033584B2 (en) | 1988-09-07 | 2006-04-25 | Omegatech, Inc. | Feeding Thraustochytriales to poultry for increasing omega-3 highly unsaturated fatty acids in eggs |
| US5985348A (en) * | 1995-06-07 | 1999-11-16 | Omegatech, Inc. | Milk products having high concentrations of omega-3 highly unsaturated fatty acids |
| US5698244A (en) * | 1988-09-07 | 1997-12-16 | Omegatech Inc. | Method for raising animals having high concentrations of omega-3 highly unsaturated fatty acids |
| US6451567B1 (en) | 1988-09-07 | 2002-09-17 | Omegatech, Inc. | Fermentation process for producing long chain omega-3 fatty acids with euryhaline microorganisms |
| US5340742A (en) * | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids |
| US5340594A (en) * | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Food product having high concentrations of omega-3 highly unsaturated fatty acids |
| US5012761A (en) * | 1988-11-17 | 1991-05-07 | Oh Suk Y | Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs |
| US6410281B1 (en) | 1992-07-10 | 2002-06-25 | Omegatech, Inc. | Reducing corrosion in a fermentor by providing sodium with a non-chloride sodium salt |
| FR2721481B1 (en) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | New dietary compositions based on phospholipids and their use as a nutritional supplement. |
| CN105567752A (en) | 2000-01-28 | 2016-05-11 | Dsmip资产公司 | Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
| US20030118714A1 (en) | 2001-12-21 | 2003-06-26 | Michael Foods Of Delaware, Inc. | Formulation and process to prepare a premium formulated fried egg |
| JP6673649B2 (en) * | 2015-06-26 | 2020-03-25 | 株式会社アキタフーズ | Spawning poultry feed |
| US20170239179A1 (en) * | 2016-02-19 | 2017-08-24 | Melanie Revucky | Flavored Water Composition For Pets |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5716784A (en) * | 1980-04-09 | 1982-01-28 | Foster Wheeler Corp | Fluidized bed type heat exchanger with fluid-cooled air distribution plate assembly |
| JPS5768745A (en) * | 1980-10-17 | 1982-04-27 | Katsuji Shimizu | Preparation of food |
-
1983
- 1983-11-14 JP JP58213613A patent/JPS60105471A/en active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5716784A (en) * | 1980-04-09 | 1982-01-28 | Foster Wheeler Corp | Fluidized bed type heat exchanger with fluid-cooled air distribution plate assembly |
| JPS5768745A (en) * | 1980-10-17 | 1982-04-27 | Katsuji Shimizu | Preparation of food |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038051A1 (en) * | 1995-05-30 | 1996-12-05 | Suntory Limited | Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60105471A (en) | 1985-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0304819B1 (en) | Animal feed supplement | |
| US5133963A (en) | Method of producing commercially useful poultry products with increased concentrations of Omega-3 polyunsaturated fatty acids | |
| Pigott et al. | Science opens new horizons for marine lipids in human nutrition | |
| EP0909132B1 (en) | Dietetic baby food formula containing conjugated linoleic acids | |
| JP4410969B2 (en) | Egg with balanced lipid composition | |
| US8323708B2 (en) | Poultry meat and eggs comprising beneficial fatty acids | |
| JPH10508189A (en) | Method for reducing animal body fat by administering conjugated linoleic acid | |
| US20090047378A1 (en) | Non marine or non algal sourced omega 3 feed/food supplement and process for stabilizing, enhancing the conversion efficiency, and enrichment of omega 3 fatty acids in livestock/humans and products therefrom | |
| JPH0551271B2 (en) | ||
| Mooney et al. | Lipid and flavour quality of stored breast meat from broilers fed marine algae | |
| JP2012520674A (en) | Poultry meat and eggs that contain beneficial fatty acids | |
| Wealleans et al. | Fats and oils in pig nutrition: Factors affecting digestion and utilization | |
| Harel et al. | Enhanced absorption of docosahexaenoic acid (DHA, 22: 6n-3) in Artemia nauplii using a dietary combination of DHA-rich phospholipids and DHA-sodium salts | |
| JPH0336493B2 (en) | ||
| A. Manilla et al. | N-3 fatty acid enrichment and oxidative stability of broiler chicken (A review) | |
| JPH0662760A (en) | Oil and fat composition enriched with nutrient feed organism for larva and juvenile fish, feed organism for larva, and the like, and raising and cultivation of larva and juvenile fish using the organism | |
| JP6035314B2 (en) | Poultry meat and eggs that contain beneficial fatty acids | |
| Yasmin et al. | Effect of conjugated linolenic acid (cis-9, trans11, cis-13-18: 3) on growth performance and lipid composition of fingerling rainbow trout Oncorhynchus mykiss | |
| JPH0371100B2 (en) | ||
| JPH02227052A (en) | Pork having improved lipid | |
| WO2010001387A2 (en) | Improved poultry meat products | |
| Poudel | Comparing rapeseed fed chicken with ordinary soybean oil fed chicken | |
| Nehra et al. | Enrichment of Essential Fatty Acids in Food | |
| JP2018057392A (en) | Useful fatty acid-containing poultry meat and poultry egg | |
| Sheppard | Specialty Eggs: n‐3 Fatty Acid‐Enriched Eggs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |